Mrs. Yun Soobeen | Medicine | Best Researcher Award

Posted on by Computer Scientists Awards

Mrs. Yun Soobeen | Medicine | Best Researcher Award

resident, Gachon University Gil Medical Center Dentistry, South Korea

Dr. Soobeen Yun is a dedicated dental professional currently serving as a Resident in the Department of Oral and Maxillofacial Surgery at Gachon University Gil Medical Center Dentistry πŸ‡°πŸ‡·. With a strong academic foundation and a growing research portfolio, Dr. Yun is emerging as a promising figure in the field of oral surgery. Her passion for clinical excellence and academic inquiry is reflected in her involvement in advanced implantology research and case-based studies.

Publication Profile

ORCID

πŸŽ“ Education Background:

Dr. Yun completed her Doctor of Dental Surgery (D.D.S.) degree from Chosun University, College of Dentistry between 2016 and 2022 πŸŽ“. Her academic training laid a solid groundwork for her subsequent residency in oral and maxillofacial surgery, enabling her to combine theoretical knowledge with practical surgical experience.

πŸ’Ό Professional Experience:

Currently, Dr. Yun holds a Resident position at Gachon University Gil Hospital in Incheon, South Korea πŸ₯, where she works in the Oral and Maxillofacial Surgery department. Her clinical duties are complemented by her active involvement in academic research, collaborative studies, and surgical innovation.

πŸ† Awards and Honors:

Though early in her career, Dr. Yun’s scholarly work and professional promise are positioning her for recognition in her field 🌟. She has already contributed to reputable journal publications and continues to engage in research that improves surgical accuracy and patient outcomes, qualifying her as a strong candidate for emerging researcher awards.

πŸ”¬ Research Focus:

Dr. Yun focuses on guided implant surgery, maxillofacial trauma, and post-surgical rehabilitation using advanced techniques such as fibula free flaps πŸ¦·πŸ”. Her current ongoing research is centered on evaluating the accuracy of guided implant surgery, contributing to improving the predictability and safety of oral surgical procedures.

πŸ”š Conclusion:

With a mix of clinical rigor, scholarly contributions, and an evolving research profile, Dr. Soobeen Yun exemplifies the qualities of a rising talent in oral and maxillofacial surgery πŸ₯ΌπŸ“ˆ. Her journey reflects commitment, innovation, and a deep desire to impact dental medicine through both hands-on care and academic excellence.

πŸ“š Top PublicationsΒ 

  1. πŸ”— Errors in guided dental implant placement on inclined surfaces with fully-guided systems

    • πŸ—“ Published: 2025

    • πŸ“˜ British Journal of Oral and Maxillofacial Surgery

    • πŸ“ˆ Cited by: 4 articles (as of latest data)

    • 🧠 Notes: This study highlights common error margins in implant placement when performed on sloped surfaces, guiding improvements in digital surgery protocols.

  2. πŸ”— Mandibular Rehabilitation with Fibula Free Flap and Dental Implant: A 4-Year Follow–up

    • πŸ—“ Published: 2024

    • πŸ“˜ Journal of Implantology and Applied Sciences

    • πŸ“ˆ Cited by: 2 articles

    • 🧠 Notes: This long-term follow-up study showcases the successful rehabilitation of mandibular defects using fibula free flap technique and subsequent dental implants.

  3. πŸ”— Refracture at the same area after zygomaticomaxillary complex fracture surgery: a case report

    • πŸ—“ Published: 2023

    • πŸ“˜ Oral Biology Research

    • πŸ“ˆ Cited by: 3 articles

    • 🧠 Notes: A rare case of post-operative refracture is detailed with clinical insights into surgical decisions and post-op patient management.

 

Prof. Jie Lu | Health Sciences | Best Scholar Award

Posted on by Computer Scientists Awards

Prof. Jie Lu | Health Sciences | Best Scholar Award

Vice advisor, The Affiliated Hospital of Qingdao University, China

Dr. Jie Lu is a distinguished medical researcher and Associate Professor at The Affiliated Hospital of Qingdao University. With a strong background in internal medicine, endocrinology, and metabolism, Dr. Lu has made significant contributions to the field of hyperuricemia and gout research. His expertise in molecular and clinical studies has led to groundbreaking findings, including the development of a spontaneous hyperuricemia mouse model and critical insights into the relationship between hyperuricemia and metabolic disorders. His research has been widely recognized, earning him prestigious awards and global collaborations.

Publication Profile

πŸŽ“ Education

Dr. Jie Lu completed his MD and PhD in Internal Medicine from Qingdao University (2015-2018), following an MS in Endocrine and Metabolism (2012-2015) from the same institution. His academic journey began with a Bachelor’s in Medicine from Shandong Second Medical University (2007-2012), laying a strong foundation for his career in medical research.

πŸ‘¨β€πŸ”¬ Experience

Dr. Lu has been serving as an Associate Professor at The Affiliated Hospital of Qingdao University since 2022. Prior to this, he worked as a Research Fellow at the same institution (2018-2022), where he played a pivotal role in advancing hyperuricemia research. His international training experience spans institutions such as the University of Otago, Henry Ford Immunology Program in the USA, and the Chinese Academy of Sciences, enriching his expertise in bioinformatics, immunology, and molecular biology.

πŸ† Awards and Honors

Dr. Lu’s excellence in medical research has been recognized through numerous prestigious awards. In 2022, he received the 13th Qingdao Youth Science and Technology Award. His contributions to scientific progress earned him the First Award of Shandong Province Science and Technology Progress in 2020. Throughout his academic career, he has been honored with multiple scholarships, including the National Graduate Scholarship (2017), Excellent Student Scholarship (2016-2017), and Freshman Scholarship (2015). His outstanding performance as a researcher and student has been acknowledged with multiple β€œExcellent Graduate” awards from Shandong Province and Qingdao University.

πŸ”¬ Research Focus

Dr. Lu’s research is dedicated to understanding the clinical and molecular mechanisms of hyperuricemia and gout. His pioneering work in constructing a spontaneous hyperuricemia mouse model has provided invaluable insights into disease progression and treatment strategies. His studies explore the relationship between hyperuricemia and renal function, diabetes, and arterial sclerosis, with high-impact publications in leading journals such as Nature Reviews Rheumatology, Kidney International, and Diabetes. He has also been instrumental in identifying the impact of COVID-19 vaccination on gout attacks, proposing colchicine as a preventive treatment.

🏁 Conclusion

Dr. Jie Lu is a leading researcher in hyperuricemia and gout, with a remarkable academic and research career. His extensive publications, international collaborations, and pioneering research have significantly contributed to the medical field. Recognized for his scientific achievements, Dr. Lu continues to make impactful discoveries that shape the future of metabolic disease treatment.

πŸ“š Publications

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination – Annals of the Rheumatic Diseases, 2022 πŸ”—

Mouse models for human hyperuricaemia: a critical review – Nature Reviews Rheumatology, 2019 πŸ”—

Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders – Kidney International, 2018 πŸ”—

Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic Ξ²-cell death in uricase-deficient male mice – Diabetes, 2020 πŸ”—

Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model – The FEBS Journal, 2019 πŸ”—

Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion – Arthritis Rheumatol, 2022 πŸ”—

Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares – Arthritis Rheumatol, 2023 πŸ”—

Profiling of Serum Oxylipins Identifies Distinct Spectrums and Potential Biomarkers in Young People with Very Early Onset Gout – Rheumatology (Oxford), 2023 πŸ”—

Effects of fenofibrate therapy on renal function in primary gout patients – Rheumatology (Oxford), 2021 πŸ”—

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study – Joint Bone Spine, 2020 πŸ”—